Analyze Diet
Veterinary surgery : VS2015; 44(6); 679-686; doi: 10.1111/j.1532-950X.2015.12314.x

Morphine Synovial Fluid Concentrations After Intravenous Regional Limb Perfusion in Standing Horses.

Abstract: To determine synovial concentrations of morphine after intravenous regional limb perfusion (IVRLP) with morphine or morphine in combination with gentamicin in clinically healthy, standing sedated horses. Methods: Experimental. Methods: Adult horses (n = 6). Methods: IVRLP was performed using 0.1 mg/kg morphine (M) in standing sedated horses. After a 3-week washout period, IVRLP was performed on the same forelimb with a combination of 0.1 mg/kg morphine and 1 g gentamicin (M/G). Synovial fluid from the middle carpal joint of the perfused limb and jugular blood samples were collected immediately before each perfusion and 20 minutes, and 2, 8, and 24 hours after IVRLP. Morphine and gentamicin concentrations were determined by ELISA. Data were assessed using 2-way repeated measures ANOVA with significance set at P ≤ .05. Results: Synovial fluid morphine concentrations were greatest 20 minutes after perfusion. Mean ± SD peak synovial morphine concentrations over 12 perfusions were 3903 ± 4881 ng/mL. There was no significant difference in morphine synovial concentrations after M or M/G. Plasma morphine concentrations peaked within 2 hours of perfusion (range, 11-63 ng/mL). Mean peak gentamicin concentrations in synovial fluid were 76,315 ± 39,809 ng/mL. IVRLP morphine did not cause clinically apparent adverse effects. Conclusions: IVRLP in standing sedated horses results in measurable levels of morphine in synovial fluid and synovial concentrations of gentamicin after perfusion in combination with morphine are equivalent to those previously reported.
Publication Date: 2015-08-01 PubMed ID: 26223568DOI: 10.1111/j.1532-950X.2015.12314.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article studies the concentration of morphine in the synovial fluid of horses after intravenous regional limb perfusion (IVRLP), either with only morphine or with gentamicin combined.

Objective & Methodology

The study aimed to find out the synovial concentrations of morphine in standing sedated horses after performing IVRLP. The research was experimental in nature and was conducted on six adult horses. The first IVRLP was performed using only morphine at a dosage of 0.1mg/kg. After a 3-week washout period, another perfusion was done on the same forelimb of each horse but this time using a combination of 0.1mg/kg of morphine and 1g of gentamicin (M/G).

  • Synovial fluid (a fluid found in joints) was collected from the middle carpal joint of the perfused limb.
  • Jugular blood samples were collected immediately before each perfusion and then at different intervals post IVRLP: 20 minutes, 2 hours, 8 hours and 24 hours.
  • Concentrations of morphine and gentamicin in these samples were determined using ELISA (enzyme-linked immunosorbent assay) – a commonly used method for measuring amounts of proteins or other substances in a solution.

The data were statistically assessed using a 2-way repeated measures ANOVA.

Results & Conclusion

The results indicated that the concentration of morphine in the synovial fluid was highest 20 minutes after the perfusion, with a mean peak concentration of 3903 ± 4881ng/mL recorded over 12 perfusions. No significant difference in the concentration of morphine was observed whether administered alone or with gentamicin.

The plasma morphine concentration peaked within 2 hours of perfusion, with a range of 11-63ng/mL. Gentamicin, when used, had a mean peak synovial fluid concentration of 76,315 ± 39,809ng/mL.

There were no clinically notable adverse effects seen after the IVRLP of morphine. The research concluded that IVRLP in sedated standing horses yields measurable levels of morphine in the synovial fluid – even when used in combination with gentamicin, the results were very much in line with those reported previously.

Cite This Article

APA
Hunter BG, Parker JE, Wehrman R, Stang B, Cebra CK. (2015). Morphine Synovial Fluid Concentrations After Intravenous Regional Limb Perfusion in Standing Horses. Vet Surg, 44(6), 679-686. https://doi.org/10.1111/j.1532-950X.2015.12314.x

Publication

ISSN: 1532-950X
NlmUniqueID: 8113214
Country: United States
Language: English
Volume: 44
Issue: 6
Pages: 679-686

Researcher Affiliations

Hunter, Barbara G
  • Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon.
Parker, Jill E
  • Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon.
Wehrman, Rita
  • Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon.
Stang, Bernadette
  • Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon.
Cebra, Christopher K
  • Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon.

MeSH Terms

  • Analysis of Variance
  • Animals
  • Drug Combinations
  • Enzyme-Linked Immunosorbent Assay
  • Forelimb / blood supply
  • Forelimb / metabolism
  • Gentamicins / administration & dosage
  • Gentamicins / pharmacokinetics
  • Horses
  • Infusions, Intravenous
  • Morphine / administration & dosage
  • Morphine / pharmacokinetics
  • Synovial Fluid / metabolism
  • Time Factors

Citations

This article has been cited 1 times.
  1. Valverde A, Cribb N, Arroyo L. Morphine concentrations in distal thoracic limb synovial fluid following intravenous regional limb perfusion in horses. Can J Vet Res 2023 Oct;87(4):254-259.
    pubmed: 37790266